TIMI

Also found in: Wikipedia

0.01 sec.

Acronym	Definition
TIMI	Thrombolysis In Myocardial Infarction
TIMI	Technology Independent Machine Interface (IBM AS/400)
TIMI	Technical Information Maintenance Instruction

How to thank TFD for its existence? Tell a friend about us, add a link to this page, add the site to iGoogle, or visit webmaster's page for free fun content.

?Page tools

Printer friendly
Cite / link

Email
Feedback

? References in periodicals archive
The electrocardiogram predicts one-year outcome of pateints with unstable angina and on-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Air pollution and ST-segment depression in elderly subjects by Stone, Peter H. / Environmental Health Perspectives C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Effect of marathon running on inflammatory and hemostatic markers by Tofler, Geoffrey H. / AMAA Journal Dr Eugene Braunwald, chairman of the TIMI Study Group said: "We are very interested in learning in this Phase II trial whether BB-10153 can successfully lyse clots and provide an acceptable safety profile in terms of bleeding risk. FDA CLEARS THROMBOLYTIC DRUG FOR PHASE II CLINICAL TRIAL by Worldwide Biotech More results

? References in periodicals archive

The electrocardiogram predicts one-year outcome of pateints with unstable angina and on-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study.

Air pollution and ST-segment depression in elderly subjects by Stone, Peter H. / Environmental Health Perspectives

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy.

Effect of marathon running on inflammatory and hemostatic markers by Tofler, Geoffrey H. / AMAA Journal

Dr Eugene Braunwald, chairman of the TIMI Study Group said: "We are very interested in learning in this Phase II trial whether BB-10153 can successfully lyse clots and provide an acceptable safety profile in terms of bleeding risk.

FDA CLEARS THROMBOLYTIC DRUG FOR PHASE II CLINICAL TRIAL by Worldwide Biotech

More results

Acronyms browser

? Full browser

TIMER
TIMEREL
TIMEREQ
TIMERESP
TIMES
TIMF
TIMG
TIMI
TIMI 3
TIMIG
TIMINT
TIMIP
TIMIS
TIMJ
TIML

Acronyms and Abbreviations

Free Tools:	For surfers: Free toolbar & extensions \| Word of the Day \| Help For webmasters: Free content \| Linking \| Lookup box \| Double-click lookup \| Partner with us

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional. Terms of Use.